Inactief instrument

Andere talen Neurometrix Inc Nasdaq

Aandelen

US6412553025

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Sector Update: Health Care Stocks Advance Late Afternoon	19/04
Sector Update: Health Care Stocks Rise Friday Afternoon	19/04
NeuroMetrix Says Joshua Horowitz Joining Board, Terminates At-the-Market Equity Facility	19/04
NeuroMetrix Announces Steps Taken to Enhance Shareholder Value	19/04
Neurometrix, Inc. Appoints Joshua S. Horowitz as a Class III director on the Board	19/04
Beyond the Pill: Athletes Champion PEMF and Non-Opioid Solutions for Pain Management (ENDV)	20/03
NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	14/03
NeuroMetrix, Inc. Announces Publication of Study Demonstrating That DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy	14/03
NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® Fibromyalgia	13/03
Ephraim Fields Discloses his Views on NeuroMetrix	27/02
RS Fund Discloses its Views on NeuroMetrix	26/02
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights	22/02
NeuroMetrix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
NeuroMetrix, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call	15/02
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	13/02
NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder Value	13/02
NeuroMetrix to Present at the Emerging Growth Conference on January 10, 2024	08/01
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)	12/12
Neurometrix, Inc. Reports Encouraging Results from Pilot Clinical Trial of Quell®? in Post-Acute Covid-19 Syndrome (Long Covid)	12/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Neurometrix Inc Nasdaq

Aandelen

US6412553025

Andere talen

Filters